2013, Número 1
<< Anterior Siguiente >>
Rev Cub de Reu 2013; 15 (1)
Correlación etiopatogénica entre periodontitis y artritis reumatoide
Hernández CMV, Hernández CIM, Amaro HR
Idioma: Español
Referencias bibliográficas: 38
Paginas:
Archivo PDF: 115.36 Kb.
RESUMEN
La artritis reumatoide y la periodontitis crónica y agresiva son enfermedades inflamatorias crónicas caracterizadas por una disregulación de la respuesta inflamatoria en un huésped inmunogenéticamente susceptible. La intensa secreción de mediadores inflamatorios condiciona la destrucción del tejido sinovial y periodontal respectivamente. Ambas enfermedades comparten factores de riesgo y tienen vías patogénicas comunes que conllevan finalmente a la pérdida de la función y discapacidad. Este artículo discute las posibles interacciones, particularmente relacionadas con el patógeno periodontal porphyromonas gingivalis, que explicaría la asociación observada entre estas enfermedades de elevada prevalencia en el marco de los más recientes descubrimientos.
REFERENCIAS (EN ESTE ARTÍCULO)
Kasser UR, Gleissner C, Dehne F, Michel A,Willershausen-Zonnchen B, Bolten WW. Risk for periodontal disease in patients with longstanding rheumatoid arthritis. Arthritis Rheum 1997; 40:2248-51.
Mercado F, Marshall RI, Klestov AC, Bartold PM. Is there a relationship between rheumatoid arthritis and periodontal disease? J Clin Periodontol 2000; 27:267-72.
Ogrendik M. Rheumatoid arthritis is linked to oral bacteria: etiological association. Mod Rheumatol 19:453-456, 2009a.
Jacqueline Detert, Nicole Pischon, Gerd R Burmester, and Frank Buttgereit The association between rheumatoid arthritis and periodontal disease Arthritis Res Ther. 2010; 12(5): 218.
Bartold PM, Marshall RI, Haynes DR. Periodontitis and rheumatoid arthritis: a review. J Periodontol. 2005 Nov;76(11 Suppl):2066-74.
Smolik I, Robinson D, El-Gabalawy HS. Periodontitis and rheumatoid arthritis: epidemiologic, clinical, and immunologic associations.Compend Contin Educ Dent. 2009 May;30(4):188-90.
Gabriel SE. The epidemiology of rheumatoid arthritis.Rheum Dis Clin North Am 2001; 27:269-81.
Karsten Conrad, Dirk Roggenbuck, Dirk Reinhold and Thomas Dörner Profiling of rheumatoid arthritis associated autoantibodies Autoimmunity Reviews Volume 9, Issue 6, April 2010, Pages 431-435
Wegner N, Lundberg K, Kinloch A, Fisher B, Malmström V, Feldmann M, Venables PJ. Autoimmunity to specific citrullinated proteins gives the first clues to the etiology of rheumatoid arthritis. Immunol Rev. 2010 Jan;233(1):34-54.
Van der Woude D., Huizinga T. W. J..Genetics: Every shared epitope allele for itself? Nature Reviews Rheumatology. 2009; 5, 477-478.
Irfan UM, Dawson DV, Bissada NF. Epidemiology of periodontal disease: a review and clinical perspectives.J Int Acad Periodontol 2001; 3:14-21.
Takashiba S, Naruishi K, Murayama Y. Perspective of cytokine regulation for periodontal treatment: fibroblast biology. J Periodontol 2003; 74:103-10.
Okada Y, Meguro M, Ohyama H et al. Human leukocyte histocompatibility antigen class II-induced cytokines from human gingival fibroblasts promote proliferation of human umbilical vein endothelial cells: potential association with enhanced angiogenesis in chronic periodontal inflammation. J Periodontal Res 2009; 44:103-9.
Arend WP, Dayer JM. Cytokines and cytokine inhibitors or antagonists in rheumatoid arthritis. Arthritis Rheum 1990; 33:305-15.
Bartold P.M., Marshall R.I., and Haynes D.R. Periodontitis and Rheumatoid Arthritis: A Review Journal of Periodontology November 2005, Vol. 76, No. 11-s, Pages 2066-2074.
El-Gabalawy H. The preclinical stages of RA: lessons from human studies and animal models. Best Pract Res Clin Rheumatol 2009; 23:49-58.
Ogrendik M, Kokino S, Ozdemir F, Bird PS, Hamlet S.Serum antibodies to oral anaerobic bacteria in patients with rheumatoid arthritis. MedGenMed 2005;7:2.
Lundberg K, Wegner N, Yucel-Lindberg T, Venables PJ.Periodontitis in RA-the citrullinated enolase connection. Nat Rev Rheumatol 2010;6:727-30.
Holt SC, Ebersole J, Felton J, Brunsvold M, Kornman KS. Implantation of Bacteroides gingivalis in nonhuman primates initiates progression of periodontitis. Science 1988;239:55-7.
McGraw WT, Potempa J, Farley D, Travis J. Purification, characterization, and sequence analysis of a potential virulence factor from Porphyromonas gingivalis, peptidylarginine deiminase. Infect Immun 1999; 67:3248-56.
Mangat P, Wegner N, Venables PJ, Potempa J. Bacterial and human peptidylarginine deiminases: targets for inhibiting the autoimmune response in rheumatoid arthritis? Arthritis Res Ther 2010; 12:209.
Schellekens GA, de Jong BA, van den Hoogen FH, van de Putte LB, van Venrooij WJ. Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies. J Clin Invest 1998; 101:273-81.
Girbal-Neuhauser E, Durieux JJ, Arnaud M et al. The epitopes targeted by the rheumatoid arthritis-associated antifilaggrin autoantibodies are posttranslationally generated on various sites of (pro)filaggrin by deimination of arginine residues. J Immunol 1999;162:585-94.
Baeten D, Peene I, Union A et al. Specific presence of intracellular citrullinated proteins in rheumatoid arthritis synovium: relevance to antifilaggrin autoantibodies.Arthritis Rheum 2001; 44:2255-62.
Van Venrooij WJ, Hazes JM, Visser H. Anticitrullinated protein/peptide antibody and its role in the diagnosis and prognosis of early rheumatoid arthritis. Neth J Med 2002;60:383-8.
Mikuls TR, Payne JB, Reinhardt RA et al. Antibody responses to Porphyromonas gingivalis (P. gingivalis) in subjects with rheumatoid arthritis and periodontitis.Int Immunopharmacol 2009;9:38-42.
Whitney C, Ant J, Moncla B, Johnson B, Page RC, Engel D. Serum immunoglobulin G antibody to Porphyromonas gingivalis in rapidly progressive periodontitis: titer, avidity, and subclass distribution. Infect Immun 1992; 60:2194-200.
Masson-Bessiere C, Sebbag M, Girbal-Neuhauser E et al. The major synovial targets of the rheumatoid arthritis-specific antifilaggrin autoantibodies are deiminated forms of the alpha- and beta-chains of fibrin. J Immunol 2001;166:4177-84.
Travis J, Pike R, Imamura T, Potempa J. Porphyromonas gingivalis proteinases as virulence factors in the development of periodontitis. J Periodontal Res 1997;32:120-5.
Szodoray P, Szabo Z, Kapitany A et al. Anti-citrullinated protein/peptide autoantibodies in association with genetic and environmental factors as indicators of disease outcome in rheumatoid arthritis. Autoimmun Rev 2009;9: 140-3.
Michalowicz BS, Diehl SR, Gunsolley JC et al. Evidence of a substantial genetic basis for risk of adult periodontitis.J Periodontol 2000;71:1699-707.
Nepom GT, Nepom BS. Prediction of susceptibility to rheumatoid arthritis by human leukocyte antigen genotyping. Rheum Dis Clin North Am 1992;18:785-92.
Bonfil JJ, Dillier FL, Mercier P et al. A ‘‘case control’’ study on the role of HLA DR4 in severe periodontitis and rapidly progressive periodontitis. Identification of types and subtypes using molecular biology (PCR.SSO). J Clin Periodontol 1999; 26:77-84.
Hill JA, Southwood S, Sette A, Jevnikar AM, Bell DA, Cairns E. Cutting edge: the conversion of arginine to citrulline allows for a high-affinity peptide interaction with the rheumatoid arthritis-associated HLA-DRB1*0401 MHC class II molecule. J Immunol 2003; 171:538-41.
Berthelot JM, Le Goff B. Rheumatoid arthritis and periodontal disease. Joint Bone Spine. 2010 Dec;77(6):537-41.
Li W, Wang M, Irigoyen P, Gregersen PK. Inferring causal relationships among intermediate phenotypes and biomarkers: a case study of rheumatoid arthritis. Bioinformatics 2006; 22:1503_7.
Wipke BT, Wang Z, Nagengast W, Reichert DE, Allen PM. Staging the initiation of autoantibody-induced arthritis: a critical role for immune complexes. J Immunol 2004; 172: 7694-702.
Willemze A, Ioan-Facsinay A, El-Gabalawy H. Anti-citrullinated protein antibody response associated with synovial immune deposits in a patient with suspected early rheumatoid arthritis. J Rheumatol 2008; 35:2282-4